Skip to content

Testimonials

More than 1,000 eye care professionals worldwide have been using the AdaptDx® and AdaptDx Pro™ to test for impaired dark adaptation, the earliest biomarker of age-related macular degeneration. Our customers tell the story of how they’re fighting against preventable blindness by identifying AMD at its earliest stages and closely monitoring its progression. 

In the first few months of using the AdaptDx, we've more than doubled our nutraceutical sales and have seen a sizable increase in optical sales associated with UV and blue light blocking protection.

R. Aaron Werner Aaron Werner, OD

The marketing package MacuLogix provides to their customers is the best I have seen with any equipment company!

dr-christa-1-300x4002 Christa Walling, OD

AdaptDx may help you find macular degeneration at least three years before you actually see any clinical signs. Do you want to wait to diagnose glaucoma until someone has a vision-threatening visual field loss? No, you don’t. And we should be thinking the same way about AMD. Let’s find it in its earliest stage so that we can do something about it and try to prevent the bad outcomes.

Gerson_Headshot_10-13 Jeffry Gerson, OD, FAAO

The MacuLogix team gives superior installation, education, and support than any ophthalmologic instrument that I can think of. By discussing and identifying your personal practice flow, recommendations and support will be given to best start making this a reflex to discuss with patients and perform in your office on a daily basis.

AmandaLegge_OD Amanda Legge, OD